» Articles » PMID: 28434038

Emerging Potential of Gene Silencing Approaches Targeting Anti-chondrogenic Factors for Cell-based Cartilage Repair

Overview
Publisher Springer
Specialty Biology
Date 2017 Apr 24
PMID 28434038
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The field of cartilage repair has exponentially been growing over the past decade. Here, we discuss the possibility to achieve satisfactory regeneration of articular cartilage by means of human mesenchymal stem cells (hMSCs) depleted of anti-chondrogenic factors and implanted in the site of injury. Different types of molecules including transcription factors, transcriptional co-regulators, secreted proteins, and microRNAs have recently been identified as negative modulators of chondroprogenitor differentiation and chondrocyte function. We review the current knowledge about these molecules as potential targets for gene knockdown strategies using RNA interference (RNAi) tools that allow the specific suppression of gene function. The critical issues regarding the optimization of the gene silencing approach as well as the delivery strategies are discussed. We anticipate that further development of these techniques will lead to the generation of implantable hMSCs with enhanced potential to regenerate articular cartilage damaged by injury, disease, or aging.

Citing Articles

Engineering gene-activated bioprinted scaffolds for enhancing articular cartilage repair.

Wang M, Wang J, Xu X, Li E, Xu P Mater Today Bio. 2024; 29:101351.

PMID: 39649247 PMC: 11621797. DOI: 10.1016/j.mtbio.2024.101351.


Women's contribution to stem cell research for osteoarthritis: an opinion paper.

Velot E, Balmayor E, Bertoni L, Chubinskaya S, Cicuttini F, de Girolamo L Front Cell Dev Biol. 2024; 11:1209047.

PMID: 38174070 PMC: 10762903. DOI: 10.3389/fcell.2023.1209047.


MicroRNA-193b-3p regulates chondrogenesis and chondrocyte metabolism by targeting HDAC3.

Meng F, Li Z, Zhang Z, Yang Z, Kang Y, Zhao X Theranostics. 2018; 8(10):2862-2883.

PMID: 29774080 PMC: 5957014. DOI: 10.7150/thno.23547.


Intra-articular drug delivery systems for joint diseases.

Rai M, Pham C Curr Opin Pharmacol. 2018; 40:67-73.

PMID: 29625332 PMC: 6015522. DOI: 10.1016/j.coph.2018.03.013.


Long noncoding RNA expression profiles in chondrogenic and hypertrophic differentiation of mouse mesenchymal stem cells.

Cao Z, Huang S, Li J, Bai Y, Dou C, Liu C Funct Integr Genomics. 2017; 17(6):739-749.

PMID: 28735352 DOI: 10.1007/s10142-017-0569-5.

References
1.
Andre E, Pensado A, Resnier P, Braz L, Rosa da Costa A, Passirani C . Characterization and comparison of two novel nanosystems associated with siRNA for cellular therapy. Int J Pharm. 2015; 497(1-2):255-67. DOI: 10.1016/j.ijpharm.2015.11.020. View

2.
Cui Z, Fan J, Kim S, Bezouglaia O, Fartash A, Wu B . Delivery of siRNA via cationic Sterosomes to enhance osteogenic differentiation of mesenchymal stem cells. J Control Release. 2015; 217:42-52. PMC: 4624027. DOI: 10.1016/j.jconrel.2015.08.031. View

3.
Fellows C, Matta C, Zakany R, Khan I, Mobasheri A . Adipose, Bone Marrow and Synovial Joint-Derived Mesenchymal Stem Cells for Cartilage Repair. Front Genet. 2017; 7:213. PMC: 5167763. DOI: 10.3389/fgene.2016.00213. View

4.
Musumeci G, Aiello F, Szychlinska M, Di Rosa M, Castrogiovanni P, Mobasheri A . Osteoarthritis in the XXIst century: risk factors and behaviours that influence disease onset and progression. Int J Mol Sci. 2015; 16(3):6093-112. PMC: 4394521. DOI: 10.3390/ijms16036093. View

5.
Wei W, Rudjito E, Fahy N, Verhaar J, Clockaerts S, Bastiaansen-Jenniskens Y . The infrapatellar fat pad from diseased joints inhibits chondrogenesis of mesenchymal stem cells. Eur Cell Mater. 2015; 30:303-14. DOI: 10.22203/ecm.v030a21. View